Unavailable
Unavailable
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/14/2025 | $224.00 | Buy | Goldman |
| 7/28/2025 | Outperform → Peer Perform | Wolfe Research | |
| 5/29/2025 | $195.00 | Equal Weight → Overweight | Wells Fargo |
| 4/15/2025 | $137.00 | Outperform → Neutral | Robert W. Baird |
| 3/26/2025 | $165.00 | Overweight | Morgan Stanley |
| 2/26/2025 | $175.00 | Buy | TD Cowen |
| 12/17/2024 | $175.00 | Overweight | Analyst |
| 12/16/2024 | $196.00 → $140.00 | Buy → Neutral | Goldman |
The board of directors of Ryder System, Inc. (NYSE:R) today announces the appointment of Tammy Romo, 63, to its board, effective January 5, 2026. Romo will serve as a member of the Audit and Finance Committees. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219927656/en/Ryder appoints Tammy Romo to its board of directors, effective January 5, 2026. "The board nominated Tammy as a director for her impressive results-oriented leadership style, proven ability to provide strategic oversight in complex public company settings, and her deep transportation expertise," says Ryder Chairman and CEO Robert Sanchez. "Tammy's experience in
Tenet Healthcare Corporation (NYSE:THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.5 billion in aggregate principal amount of senior secured first lien notes due on November 15, 2032, which will bear interest at a rate of 5.500% per annum (the "first lien notes"), and $0.75 billion in aggregate principal amount of senior notes due November 15, 2033, which will bear interest at a rate of 6.000% per annum (the "senior notes" and together with the first lien notes, the "notes"). The aggregate principal amount of senior notes to be issued in the offering was increased to $0.75 billion from the previously announced amoun
Tenet Healthcare Corporation (NYSE:THC) today announced private placement offerings of $1.5 billion in aggregate principal amount of new senior secured first lien notes due 2032 (the "first lien notes") and $0.5 billion in aggregate principal amount of new senior notes due 2033 (the "senior notes" and together with the first lien notes, the "notes") to refinance $2.0 billion of its currently outstanding notes. Completion of the notes offering is subject to, among other things, pricing and customary closing conditions. Tenet intends to use the net proceeds from the sale of the notes, after payment of fees and expenses, to finance, together with cash on hand, the redemption of all of the ag
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
4 - TENET HEALTHCARE CORP (0000070318) (Issuer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
8-K - TENET HEALTHCARE CORP (0000070318) (Filer)
Goldman resumed coverage of Tenet Healthcare with a rating of Buy and set a new price target of $224.00
Wolfe Research downgraded Tenet Healthcare from Outperform to Peer Perform
Wells Fargo upgraded Tenet Healthcare from Equal Weight to Overweight and set a new price target of $195.00
The board of directors of Ryder System, Inc. (NYSE:R) today announces the appointment of Tammy Romo, 63, to its board, effective January 5, 2026. Romo will serve as a member of the Audit and Finance Committees. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219927656/en/Ryder appoints Tammy Romo to its board of directors, effective January 5, 2026. "The board nominated Tammy as a director for her impressive results-oriented leadership style, proven ability to provide strategic oversight in complex public company settings, and her deep transportation expertise," says Ryder Chairman and CEO Robert Sanchez. "Tammy's experience in
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Vineeta Agarwala, M.D., PhD, to its Board of Directors, effective immediately. Dr. Agarwala will serve as a member of the Quality, Compliance, and Ethics Committee, as well as the Human Resources Committee, increasing the size of the Board to 13 directors. "We are pleased to welcome Dr. Vineeta Agarwala to the Tenet Board," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "Vineeta is a leader in healthcare in her own right. Her expertise in innovative technologies, including applications of artificial intelligence will enhance our governance in a rapidly evolving healthcare marketplace." Dr
Tenet Healthcare Corporation (NYSE:THC) today announced the appointment of Senator Roy Blunt to the Tenet Board of Directors, effective immediately. Senator Blunt will serve as a member of the Audit Committee, Nominating and Corporate Governance Committee, and Environmental, Social, and Governance Committee. This appointment expands the Board to 12 directors, 11 of whom are independent members. "We are pleased to welcome Senator Roy Blunt as a new board member," said Saum Sutaria, M.D., Chief Executive Officer of Tenet. "With more than 25 years of legislative experience, Roy's expertise in public policy and addressing cross-cutting issues will be invaluable to helping Tenet make a lasting
Tenet Healthcare Corporation (NYSE:THC) will release its third quarter 2025 results before the market opens on Tuesday, October 28, 2025, to be followed by a conference call at 9:30 a.m. CT (10:30 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. W
Tenet Healthcare Corporation (NYSE:THC) will release its second quarter 2025 results before the market opens on Tuesday, July 22nd, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. W
Tenet Healthcare Corporation (NYSE:THC) will release its first quarter 2025 results before the market opens on Tuesday, April 29, 2025, to be followed by a conference call at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive of the call may be accessed through the investor relations section of Tenet's website at www.tenethealth.com/investors. About Tenet Healthcare Tenet Healthcare Corporation (NYSE:THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We als
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G/A - TENET HEALTHCARE CORP (0000070318) (Subject)
SC 13G - TENET HEALTHCARE CORP (0000070318) (Subject)